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Abstract
Background & Aims—Immune responses in the intestine are controlled by regulatory T cells
(Treg cells), which prevent inflammation in response to commensal bacteria. A specific population
of intestinal dendritic cells (DCs), marked by expression of CD103, generate Tregs more
efficiently than other DC populations, through mechanisms that involve retinoic acid and
transforming growth factor (TGF)-β. However, it is not clear how CD103+ DCs are specialized for
this function. We investigated the ability of CD103+ DCs to promote Treg generation through
activation of TGF-β and the role of integrins with the αv subunit in this process.
Methods—Naïve T cells were cultured with purified DCs from mesenteric lymph nodes (MLNs)
or intestines of wild-type and αv conditional knockout mice, to assess generation of Treg cells.
Antigens were administered orally to mice and antigen-specific generation of Treg cells was
measured in intestinal tissues. Expression of the integrin αv subunit was measured in purified
subpopulations of DCs by quantitative PCR and immunoblot analyses.
Results—In vitro, CD103+ DCs generated more Treg cells in the presence of latent TGF-β than
other MLN DCs. Efficient generation of Treg cells required expression of the integrin αv subunit
by DCs; mice that lacked αv in immune cells did not convert naïve T cells to intestinal Treg cells
in response to oral antigen. CD103+ DCs derived from the MLNs selectively expressed high levels
of integrin αvβ8, compared with other populations of DCs.
Conclusions—Expression of αvβ8 is required for CD103+ DCs to become specialized and
activate latent TGF-β and generate Treg cells during the induction of tolerance to intestinal
antigens in mice.
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Introduction
In the gastrointestional tract, the immune system must protect against potential pathogens
whilst preventing destructive inflammatory responses to the host’s commensal microbiota 1.
This is achieved in part through a complex and active network of specialized immune cells
and regulatory cytokines 2. Breakdown of this dynamic balance between immune response
and regulation is considered a major contributor to Inflammatory Bowel Disease (IBD) 3.
Regulatory T cells (Tregs), characterized by expression of the forkhead transcription factor
FoxP3, are an important component of intestinal immune regulation and loss of Tregs causes
spontaneous colitis, driven by microbial products in the gut 4. A major population of FoxP3+
Tregs develop from self-reactive cells in the thymus and these ‘naturally occurring’ nTregs
appear to regulate autoimmunity 5. FoxP3+ expression can also be stimulated in naïve T
cells in the periphery, providing an additional source of Tregs 6, 7 with a different potential
antigen repertoire to nTregs. Development of these ‘adaptive’ or induced Tregs (iTregs)
requires low levels of antigen and costimulation, combined with the immunoregulatory
cytokine TGF-β 8, 9. The generation of iTregs may be of particular importance in mucosal
tissues such as the intestine, as it provides a mechanism by which tolerance can be induced
against dietary antigens and the commensal microflora4.
Recently, a specific population of dendritic cells (DCs) from the mouse intestinal lamina
propria and MLNs, marked by surface expression of αE integrin chain (CD103), were
implicated in the generation of iTregs 10, 11.. In co-culture with naïve CD4+ T cells, CD103+
DCs produced more FoxP3+ Tregs than their CD103− counterparts 10, 11. The induction of
Tregs by these DCs could be prevented by neutralization of TGF-β and retinoic acid (RA);
conversely addition of exogenous TGF-β and/or RA promoted Treg generation to similar
levels in both CD103+ and CD103− DCs. Therefore the preferential induction of FoxP3+
Tregs by CD103+ DCs was due to promotion of TGF-β and RA signaling to T cells. It has
been shown that CD103+ DCs produce high levels of RA which in turn stabilizes TGF-β-
induced FoxP3 expression in T cells whilst inhibiting Th17 differentiation. However, little is
known of the contribution of CD103+ DCs to TGF-β production, despite the requirement for
TGF-β for the effects of RA. We therefore set out to determine whether CD103+ DCs were
also specialized for promoting TGF-β signaling.
Here we present evidence that enhanced generation of FoxP3+ Tregs by CD103+ DCs is also
due to their ability to activate latent TGF-β. Thus, MLN CD103+ DCs generate higher
numbers of Tregs than CD103− DCs when cultured in the presence of latent, but not active
TGF-β. This is dependent on DC expression of αv integrins in vitro and in vivo, and mice
lacking αv in the immune system are unable to generate intestinal Tregs from naïve T cells
in response to oral antigen. Furthermore, MLN CD103+ DCs alone express the αvβ8 integrin
heterodimer. Hence these data show that the expression of αv integrins by intestinal DCs is
critical for the generation of FoxP3+ Tregs in response to intestinal antigens, and that the
CD103+ subset of DCs are uniquely specialized for this function through the expression of
αvβ8 allowing activation of latent TGF-β.
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Results and Discussion
CD103+ MLN DCs activate latent TGF-β to generate FoxP3+ Tregs
In agreement with previous studies 10, 11, we found that CD103+ DCs from mouse MLNs
generated on average twice as many FoxP3+ T cells in in vitro co-culture than their CD103−
counterparts (Figure 1A). This was dependent on TGF-β as TGF-β blocking antibodies
completely prevented Treg generation by both CD103+ and CD103− DCs (Figure 1A).
FoxP3 induction was also significantly impaired when DCs and T cells were cultured in
serum free medium (Figure 1B–C), despite comparable T cell proliferation to that seen in
serum-replete medium (data not shown), indicating that the majority of TGF-β responsible
for Treg generation was derived from serum in the culture medium, rather than endogenous
production by DCs or T cells. However, it is worth noting that even in serum-free
conditions, CD103+ DCs from control mice produced more Tregs than CD103− DCs (Figure
1C).
Based on these data, we reasoned that CD103+ DCs may be better able to utilize exogenous
TGF-β to promote FoxP3 expression in T cells. TGF-β is synthesized as an inactive ‘latent’
precursor which must be dissociated from binding proteins before it can engage TGF-β
receptors, a process known as TGF-β activation. When MLN DCs were cultured with
purified latent TGF-β, CD103+ DCs again induced significantly more FoxP3+ Tregs than
CD103− cells (Figure 1B–C). These data suggested to us that the difference in Treg
generation between CD103+ and CD103− DCs might be explained in part by a differential
ability to activate latent TGF-β.
The preferential generation of Tregs by CD103+ Dcs has previously been linked to
expression of high levels of aldh1a2 which confers on this DC subset the ability to
synthesize and secrete RA, which promotes Treg generation 10, 11. Consistent with these
studies, CD103+ and CD103− DCs produced equivalent proportions of FoxP3+ Tregs when
cultured with active TGF-β and RA (Figure 1D). However, addition of RA was not
sufficient to allow CD103− DCs to efficiently generate Tregs in response to latent TGF-β.
Therefore, the increased induction of FoxP3+ Tregs by CD103+ DCs was in part due to
increased activation of latent TGF-β, independent of their ability to produce RA.
Intestinal CD103+ DCs activate TGF-β via αv integrins
αv integrins are important physiological activators of latent TGF-β and mice deficient in
both αvβ6 and αvβ8, or lacking the integrin binding site in the latency-associated peptide
(LAP), develop phenotypes closely resembling TGF-β knockouts 12, 13. We have previously
reported that mice lacking αv integrins in myeloid cells have reduced numbers of intestinal
Tregs and develop spontaneous colitis, and that DCs from the MLN of αv-deficient mice are
impaired in their ability to induce Tregs in culture14. To determine whether this was due to
specific defects in CD103+ DCs, CD103+ and CD103− DCs were sorted from the MLN of
αv-tie2 and control mice and cultured with naïve FoxP3-GFP T cells. CD103+ DCs from αv-
knockout mice did not exhibit the enhanced generation of Tregs seen in CD103+ DCs from
control mice, and instead induced similar numbers of Tregs to CD103− DCs (Figure 2A–B).
We then tested the ability of αv-deficient DCs to activate TGF-β. In the presence of latent
TGF-β, αv-deficient CD103+ DCs did not generate as many Tregs as CD103+ DCs from
wild-type mice, and only produced similar proportions to CD103− DCs, as we had seen in
cultures with serum (Figure 2C). In contrast, active TGF-β stimulated Treg generation by
αv-deficient CD103+ DCs to levels close to those seen in control CD103+ DCs (Figure 2D).
The small difference in Treg generation between CD103+ DCs from control and αv-deficient
cells in the presence of active TGF-β could be rescued by addition of RA (Figure 2E)
suggesting that αv-deficient DCs may have a slightly reduced ability to generate RA.
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However, the ability of αv-deficient CD103+ DCs to generate Tregs in the presence of latent
TGF-β was not rescued by the addition of RA (Figure 2E). These data therefore indicate that
MLN CD103+ DCs require αv integrins to activate latent TGF-β and generate Tregs. We
interpret the small induction of FoxP3+ Tregs by CD103− DCs or αv-deficient cells in
cultures with latent TGF-β as a result of a small amount of contaminating active TGF-β in
the latent TGF-β preparation, although it is possible that this results from activation of latent
TGF-β by an αv-independent mechanism.
As MLN CD103+ DCs originate in the intestinal lamina propria, we tested whether all
intestinal DCs exhibited a similar ability to activate TGF-β, or whether this was similarly
restricted to CD103+ DCs. Consistent with a specialized function for CD103+ Dcs in both
intestine and MLN, CD103+ DCs from both small intestine and colon induced more Tregs
than CD103− DCs in the presence of latent TGF-β (Figure 3). Furthermore, as for MLN
DCs, this was dependent on expression of αv integrins, and αv-deficient DCs from the
intestine induced similar numbers of FoxP3+ Tregs to CD103− DCs from either αv-
knockout or control mice (Figure 3). Together these data show that the preferential ability of
intestinal CD103+ DCs to promote Treg generation in vitro is dependent on expression of αv
integrins and appears to be due to an increased activation of latent TGF-β.
αv is required for intestinal conversion of peripheral T cells to FoxP3+ Tregs
CD103+ DCs are thought to be responsible for the generation of gut-homing Tregs from
naïve T cells in vivo. 10, 11. αv-conditional knockout mice have fewer intestinal FoxP3+
Tregs than control littermates, and develop spontaneous colitis 14. We have hypothesized
that this is due to failure of peripheral conversion of CD4+ T cells specific for intestinal
antigens to FoxP3+ Tregs (so-called induced Tregs [iTregs]), which are required to regulate
intestinal immunity.. In contrast, Tregs in lymphoid organs, which probably represent
primarily ‘natural Tregs’ of thymic origin are unaffected by αv deficiency 14. Consistent
with this hypothesis, we recently showed that naïve CD4+ T cells adoptively transferred into
αv-deficient lymphopenic SCID recipients do not differentiate into intestinal FoxP3+ Tregs,
unlike T cells transferred into αv-expressing SCID mice 15.
To test directly for the requirement for αv integrins in iTreg generation, we used a model of
oral antigen-dependent Treg conversion 8, 10, 11. αv-tie2 14 and littermate control mice were
adoptively transferred with T cells from DO11.10 mice that express a transgenic TCR
specific for ovalbumin. Recipients were then fed ovalbumin dissolved in drinking water for
five consecutive days. After oral ovalbumin administration, DO11.10+ T cells were readily
detected in small intestine and colon lamina propria, as well as the MLN and PP, of control
recipients. A significant proportion of these cells expressed FoxP3 (between 10 and 40%
depending on tissue examined; Figure 4 and data not shown), representing Tregs that had
converted from naïve T cells in the intestinal environment in response to oral
antigen 8, 10, 11. In contrast, very few converted FoxP3+ DO11.10 cells were found in the
intestine and intestinal lymph organs of αv-tie2 recipients (less than 8% in all tissues; Figure
4). As reported in other studies, almost no FoxP3+ DO11.10 cells were recovered from the
intestine or lymph nodes of mice that did not receive ovalbumin, regardless of their
genotype (data not shown). Thus, the induction of FoxP3+ Tregs in response to oral antigen
was substantially impaired in αv-knockout mice.
αvβ8 integrin is preferentially expressed on DCs from mucosal tissues
The data presented above suggested that the preferential ability of MLN CD103+ DCs to
generate Tregs in vitro and in vivo was due to their ability to activate TGF-β via αv
integrins. αv associates with 5 different β subunits, β1, β3, β5, β6 and β8, and all have been
shown to bind and activate TGF-β, albeit through different mechanisms and in different cell
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types 16. To identify the specific αv integrin responsible for the preferential activation of
TGF-β, we analyzed the expression of αv and pairing β integrins in DCs. We first compared
integrin expression by MLN DCs with DCs from the spleen, by RT-PCR. αv, β3 and β5
integrins (encoded by genes Itgav, Itgb3 and Itgb5 respectively) were all expressed at
equivalent levels in spleen and MLN DCs and β6 could not be detected in any DCs (Figure
5A). Strikingly, expression of β8 (Itgb8) was only detected in MLN DCs but not in spleen
DCs. This was confirmed using QRT-PCR, which is significantly more sensitive than rt-
PCR (Figure 5C). To determine whether these differences in gene expression led to changes
in protein, we measured expression of β8 protein by western blot (suitable antibodies against
mouse αvβ8 are not available for FACs). β8 could be readily detected in DCs from the
MLNs but not spleen (Figure 5D) confirming that changes in β8 gene expression correlate
with β8 protein levels.
We then tested whether β8 was differentially expressed between MLN DC subpopulations.
CD11c+ DCs from the MLNs were sorted by FACs based on CD103 and CD8α expression,
and β8 expression measured (Figure 5A–C). The vast majority of β8 expression seen in
MLN DCs was from the CD103+ subset and little or no expression could be seen by RT-
PCR in CD8α+ or CD8α/CD103 double negative cells (the majority of which correspond to
CD11b+ DCs). This was confirmed by QRT-PCR analysis, which indicated at least 10-fold
higher levels β8 in CD103+ DCs compared with other MLN DCs.
Finally, we analysed αv and β integrin expression in DC subsets from peripheral lymph
nodes, such as those that drain the skin, to determine whether β8 expression was limited
solely to DCs derived from the intestine. We found that β8 was also selectively expressed by
the CD103+ subpopulation of DCs from peripheral lymph nodes (Figure 5E), indicating a
potential common role in generating Treg cells for CD103+ DCs in peripheral lymph nodes.
However, it should be noted that expression was considerably lower than seen in MLN
CD103+ DCs. Indeed, it is interesting that DCs could be readily clustered into the CD103+,
CD8α+ and DN subsets based solely on relative expression of αv and pairing β integrins, the
only exception being CD103+ DCs from the spleen. β8 could not be detected by QRT-PCR
of RNA in this small population of cells and they instead clustered with CD8α+ DCs in our
analysis.
Analysis of expression of αv integrins therefore indicated that the preferential ability of
CD103+ DCs to activate TGF-β and generate Tregs is most likely due to expression of αvβ8,
which is present at much higher levels on this DC subset in the intestinal lymph nodes. This
is in agreement with studies of β8 integrin conditional knockout mice, which have a similar
phenotype to αv knockouts, developing colitis associated with loss of intestinal Tregs.
Hence β8 appears to be the critical partner for αv in activation of TGF-β by DCs, conferring
the preferential ability of CD103+ DCs to generate Tregs in the presence of latent TGF-β.
Discussion
A specific population of intestinal DCs, marked by expression of CD103, are emerging as
important regulators of intestinal immunity through their ability to promote conversion of
naïve T cells to FoxP3+ regulatory T cells that home to the intestine. Here we present data
showing that the increased ability of CD103+ DCs to generate Tregs both in vitro and in vivo
is completely dependent on the expression of αv integrins. This is due to an increased ability
of CD103+ DCs to activate latent TGF-β, and CD103+ DCs are uniquely specialized for this
role through expression of high levels of αvβ8, which is restricted to this lineage of cells.
These data build on our previous work 14 in which we demonstrated that deletion of αv from
immune cells caused spontaneous colitis in mice. This was associated with a reduction in the
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numbers of FoxP3+ Tregs in the intestine, but not in lymph nodes or spleen, which we
postulated was due to the selective loss of iTregs 14, 17. Critically, this was caused by the
deletion of αv, or the pairing β8 subunit 18, from DCs, suggesting that αvβ8 was essential for
DCs to generate intestinal iTregs. Here we demonstrate that this is the case and identify
CD103+ DCs as the αvβ8 expressing DCs responsible. We therefore propose a model in
which activation of latent TGF-β is tightly controlled by DCs, which ‘license’ TGF-β
signaling to interacting naïve T cells in an antigen-dependent manner. This is supported by
our recent work showing that T cell responses to latent TGF-β requires cognate interaction
with αv-expressing DCs15. This mechanism appears to be of particular importance in tissues
such as the intestine which are rich in latent TGF-β, and allows DCs to regulate TGF-b
signaling to DCs regardless of the source of TGF- β. We have not directly addressed the
source of TGF-β in this study, relying on exogenous addition of latent or active forms.
However, it is likely T cells represent a major source in vivo as deletion of Tgfb1 in T cells
alone led to a phenotype similar to that seen in DC-specific αv and β8 knockouts 19.
We have recently reported that a similar αv-mediated mechanism regulates the
differentiation of Th17 cells, which share a common precursor and a requirement for TGF-β
early in development 15. In that study, we did not identify the population of DCs required for
TGF-β activation in Th17 responses, although they almost certainly express β8 as similar
defects in Th17 cell generation were reported for DC-specific β8 knockout mice 20.
Supportive of this, DCs associated with Th17 cell induction in response to commensal
bacteria have also been shown to upregulate itgav and itgb8 expression 21. Upregulation of
β8 in DCs is therefore a prerequisite for generation of TGF-β dependent T cell responses. It
was striking to us that β8 expression was highly restricted to intestinal CD103+ DCs but was
not seen in CD103+ DCs from the spleen, suggesting that β8 expression may be stimulated
in response to signals encountered in the intestinal microenvironment. These may be derived
from intestinal epithelial cells, which promote the ability of DCs to generate Tregs 22, or
from commensal bacteria 21. Similar signals in skin, lung and other mucosal sites may also
promote the expression of β8 (Figure 5), and our observation that αv-tie2 mice develop
inflammation in multiple tissues, including the lung and respiratory tract, show that similar
regulatory mechanisms are likely to exist throughout the body14.
RA has also been implicated in the preferential generation of intestinal iTregs by CD103+
DCs10, 11. In addition to stimulating expression of gut homing receptors α4β7 integrin and
CCR6 23, 24, RA enhances Treg generation through promotion and stabilization of FoxP3
expression. Our data indicate that αvβ8 and RA have complementary roles in Treg
generation. Hence, DC αv integrins are essential for generation of both iTreg and Th17
cells 14, 15 by mediating activation of TGF-β whereas RA acts downstream of αv to promote
TGF-β-driven Treg generation by stabilization of FoxP3 expression and reciprocal inhibition
of Th17 differentiation25, 26. RA may therefore play a more important role in maintaining
the appropriate balance between Treg and Th17 cells, than in initiating regulatory T cell
responses.
Taken together our data support a model in which intestinal CD103+ DCs are specialized for
their role in inducing immune tolerance to oral antigens and the commensal microbiota
through expression of αvβ8 integrin. These cells are uniquely placed to utilize the high
levels of latent TGF-β present in the intestine to promote immunoregulatory T cell responses
in interacting T cells. Hence, Treg induction is restricted by availability of TGF-β, by the
lineage of the DC encountered and by the antigen specificity of the T cell. Our findings
highlight the critical role of CD103+ DCs in inducing and maintaining intestinal tolerance
and identify modulation of αvβ8 expression or function as a potential therapeutic target in
inflammatory bowel disease.
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Materials and Methods
Mice
αv-tie2 mice14, 15 backcrossed to BALB/c or C57BL/6 backgrounds (10 generations) were
used. FoxP3 eGFP reporter mice were obtained from Vijay Kuchroo (Brigham and
Women’s Hospital, Boston, MA) 8 and DO11.10 mice from Jackson Labs (Bar Harbor,
ME). All animals were housed under specific pathogen free conditions at Massachusetts
General Hospital. Animal experiments were performed under appropriate licenses within
local and national guidelines for animal care.
In vitro Treg generation assay
CD4+ T cells were sorted by magnetic separation (CD4+ pre-enrichment kit, Stem Cell
Technologies) from splenocytes of FoxP3-GFP mice. Naïve CD4+CD62LhiFoxP3-GFP− T
cells were further sorted by FACs. For MLN DCs, MLNs were digested in RPMI1640
containing DNaseI (20 mg/ml) and Liberase TL (0.33 mg/ml; both from Roche) followed by
incubation in PBS/2% BSA/10 mM EDTA. Filtered cell suspensions were enriched for DCs
using an Optiprep gradient (SIGMA) and CD11c+ CD103+ and CD103− DCs further sorted
by FACS. To prepare intestinal DCs, mice were first injected subcutaneously with B16 cells
secreting Flt3-L 27 to increase yield of DCs. Lamina propria cells were prepared as
described previously 15 and DCs enriched and FACS sorted as for MLN DCs. Naïve spleen
T cells and MLN DCs were co-cultured in either RPMI 1640 medium supplemented with 10
% fetal bovine serum and 10 mM HEPES, or in serum free X-VIVO 15 medium (LONZA).
Both media also contained 2 mM L-glutamine, 100 U/ml penicillin, 100 μg/ml streptomycin
and 50 μM 2-β-mercaptoethanol. Cells were cultured in 500 μl volume containing 1–2 × 104
DCs and 2.5–5 × 104 naïve CD4+ T cells (1:5 DC:T cell ratio), in the presence of 0.5 μg/ml
anti-CD3 antibody (145-2C11; BD Biosciences). Additional cytokines used were
recombinant active-TGF-β1 (0.5 ng/ml) and purified human latent TGF-β (2 ng/ml; both
from R&D Systems). Where stated cells were cultured in presence of 40 μg/ml blocking
anti-TGF-β1, 2, 3 antibody (1D11; R&D Systems) or all-trans retinoic acid (100 nM;
SIGMA). Cells were cultured for 4–5 days before analysis of Treg generation assessed by
GFP expression.
In vivo Treg generation
CD4+ T cells were sorted from the spleen and peripheral lymph nodes of DO11.10 Tg mice
by depletion (Miltenyi Biotech) and adoptively transferred into BALB/c-background αv-tie2
mice or littermate controls. Each mouse received 106 cells. Recipients were maintained on
either normal drinking water, or a 1.5 % solution of ovalbumin (grade V; Sigma-Aldrich) for
5 days. On day 6, lymphocytes were isolated from MLNs, Peyer’s patches and intestinal
lamina propria of recipients 15 and FoxP3 expression in transferred cells assessed by FACS.
αv integrin expression analysis
DCs from spleen, MLN and intestine as described above. PLN and Peyer’s patch DCs cells
were prepared as for MLN. DCs were then sorted by FACS based on CD11c, CD103 and
CD8α directly into TRIZOL LS (SIGMA) for RNA extraction. cDNA was synthesized using
High Capacity Reverse Transcription kit (ABiosystem) and RT-PCR was performed with
Taq DNA polymerase kit (TaKaRa) and analyzed on 1.4 % agarose gel. For real-time PCR
analysis, αv and pairing β integrins levels were quantified using Eppendorf real-time PCR
system according to manufacturer’s instructions in SYBR green master mix (Applied
Biosystems). Expression was normalized to the housekeeping gene β-actin.
PAÏDASSI et al. Page 7
Gastroenterology. Author manuscript; available in PMC 2012 November 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Western blotting
DCs were sorted (>95%) from spleen and MLN leukocytes using CD11c microbeads
(Miltenyi Biotech) and lysed in RIPA buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 %
NP-40, 0.5 % Sodium deoxycholate, 0.1 % SDS, 5 mM EDTA) containing Complete
protease inhibitor cocktail (Roche). Lysates were separated by MOPS-12 % PAGE,
transferred to PVDF membrane and immunoblotted with antibodies against β8 integrin 28
and β-actin (AC-74; SIGMA).
Antibodies
The following antibodies were used: anti-CD11c-APC (HL3), anti-CD103-PE (M290), anti-
CD8α-FITC (53-6.7), anti-CD4-APC (RM4-5), DO11.10 clonotypic antibody (KJ-1.26),
anti-CD62L-PE (MEL-14; all from BD Bioscience), anti-CD11b-FITC (M1/70) and anti-
FoxP3 (FJK-16S) (eBioscience),
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Figure 1. CD103+ DCs promote Treg generation in the presence of latent TGF-β
Naïve CD4+ FoxP3− T cells were cultured with FACS-sorted CD103+ and CD103− DCs
from MLNs in the presence of anti-CD3. The proportion of FoxP3+ T cells generated was
measured after 5 days by FACS. (A) Cells were cultured in medium containing 10% fetal
calf serum and anti-CD3, with or without the addition of neutralizing antibodies against
TGF-β (TGF-β ab). (B–D) Cells were cultured in serum-free medium, with or without the
addition of latent TGF- β, active TGF-β or RA as indicated. Representative FACS plots are
shown in (B). Cells are gated on CD4+ cells, FoxP3 gates are indicated (gate position was
set to give 0% positive cells in unstained samples). (C,D) show data from all samples in the
same experiment. In all cases data points show mean ± standard deviation of at least three
separate DC: T cell cultures and similar results were seen in three (C) or two (D)
independent experiments. *, p<0.05, student’s t-test.
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Figure 2. Enhanced generation of Tregs and TGF-β activation by MLN CD103+ DCs is
dependent on αv integrins
Naïve CD4+ FoxP3− T cells were cultured with FACS-sorted CD103+ and CD103− DCs
from MLNs of αv-tie2 (αv-ko) and control mice in the presence of anti-CD3. The proportion
of FoxP3+ T cells generated was measured after 5 days by FACS. (A, B) Cells were cultured
in medium containing 10% fetal calf serum and anti-CD3. Representative FACS plot are
shown in (A), gated on CD4+ cells, FoxP3 gates are indicated (gates position was set to give
0% positive cells in unstained samples) and data from one experiment are shown in (B). (C–
E) Cells were cultured in serum-free medium, with or without the addition of latent TGF- β,
active TGF- β and RA as indicated. In all cases data points show mean ± standard deviation
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of at least three separate DC: T cell cultures and similar results were seen in three (B–D) or
two (E) independent experiments. *, p<0.05, student’s t-test.
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Figure 3. Enhanced generation of Tregs and TGF-β activation by intestinal CD103+ DCs also
requires αv integrins
Naïve CD4+ FoxP3− T cells were cultured with FACS-sorted CD103+ and CD103− DCs
from MLNs, small intestine and colon lamina propria of Flt3-L expanded αv-tie2 (αv-ko)
and control mice in the presence of anti-CD3 and latent TGF-β in serum-free medium. The
proportion of FoxP3+ T cells generated was measured after 5 days by FACS. Figure shows
mean ± standard deviation of at least three separate DC:T cell cultures and similar results
were seen in two independent experiments. *, p<0.05, student’s t-test.
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Figure 4. αv is required for conversion naïve T cells to FoxP3+ Tregs in response to oral antigen
CD4+ T cells from DO11.10 TCR transgenic mice were adoptively transferred to αv-tie2 or
littermate control mice. Recipients were fed ovalbumin in drinking water for 5 d. On day 6,
conversion of transferred cells to FoxP3+ Tregs was assessed in various tissues by
intracellular staining for FoxP3 and FACS. (A) Isolated cells were gated on T cells by CD4
staining and size, and DO11.10-derived T cells identified by staining with the clonotypic
antibody (KJ-1.26) (left panel). The proportion of DO11.10 T cells that had converted to
Tregs was determined by FoxP3 staining (right panel). Representative staining of cells
isolated from colonic lamina propria is shown. Numbers show percentage of DO11.10 and
FoxP3+ cells. (B) Percentage of FoxP3+ cells within the transferred DO11.10 population in
Peyer’s patches (PP), mesenteric lymph nodes (MLN) and colonic lamina propria (colon).
Circles represent individual mice (n=3 mice/group for PP and colon, n=7 for MLN), bars
show mean +/− s.e.m. *, p<0.05, student’s t-test. Data were combined from two independent
experiments in which the same results were seen.
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Figure 5. αvβ8 is preferentially expressed by CD103+ DCs from the mesenteric lymph nodes
DC subpopulations from various tissues were sorted by FACS and expression of αv and
pairing β subunits were measured by rt-PCR, QRT-PCR and western blot. (A–C) DCs from
spleen and mesenteric lymph nodes were sorted on the basis of expression of CD11c,
CD103 and CD8α. (A) rt-PCR analysis of integrin and actin expression in total spleen and
MLN DCs and subpopulations. (B) representative FACs plot of CD11c+ DCs from spleen
and MLN showing gating strategy for isolating indicated populations. (C) QRT-PCR
analysis of the same samples in (B). Histogram shows mean ± s.e.m. from three independent
experiments. (D) Western blot of CD11c+ DCs from spleen and MLN stained with an
antibody against β8. Also shown is staining for actin to confirm equal levels of protein
loading. The same result was seen in two independent experiments. (E) Hierarchical
clustering of DC subpopulations from spleen, MLN and peripheral lymph nodes (PLNs)
based on integrin gene expression (determined by QRT-PCR analysis, using mean
expression from at least two independent cell and RNA preparations per DC subset). DCs
cluster into three principal groups discriminated by expression of β8 and β3 integrins.
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